Ehab Eltahawy, MD
Urology · Sleepy Hollow, NYNPI 1306173661
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (41.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Boston Scientific at 30.2% of the total. Reporting peaked in 2024 at $2,962 and has fallen 99.5% since, to $14 in 2025.
Across 61 payments — averaging $94.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Intuitive Surgical$2K
- Siemens Medical Solutions USA, Inc.$935
- Medtronic$416
- Angiodynamics, Inc.$375
- Coloplast$231
- plus $472 from 7 others
What the payments were for
- Travel & lodging$2,40242%
- Food & beverage$1,83332%
- Education$1,50026%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 16 | $1,729 |
| Intuitive Surgical | 2 | $1,577 |
| Siemens Medical Solutions USA, Inc. | 10 | $935 |
| Medtronic | 4 | $416 |
| Angiodynamics, Inc. | 3 | $375 |
| Coloplast | 19 | $231 |
| Koelis Inc. | 1 | $96 |
| AbbVie | 1 | $89 |
| Neotract Inc. | 1 | $85 |
| Cook Medical LLC | 1 | $81 |
| AstraZeneca | 1 | $55 |
| Antares Pharma, Inc. | 1 | $50 |
| Calyxo, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,500
- GREENLIGHT$967
- INTERSTIM$367
- AMS$321
- Nanoknife$277
- GENERAL MALE SUI$106
How this compares
$5,734 in reported general payments places this provider in the 70th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 69 | $51,751 |
| Tamsulosin Hcl | 144 | $2,731 |
| Silodosin | 21 | $2,202 |
| Finasteride | 74 | $1,086 |
| Trospium Chloride | 26 | $1,041 |
| Solifenacin Succinate | 14 | $979 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 19 | $610 |
| Cephalexin | 25 | $346 |
| Oxybutynin Chloride ErOxybutynin Chloride | 15 | $301 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 34 | $185 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $182 |
Paid to pharmacies, not to this prescriber.
Other urology in Sleepy Hollow
- Mahmoud KhalilSleepy Hollow$53K
- Peter WalterJamestown$1.9M
- Christopher PieczonkaSyracuse$797K
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Jeffrey SpencerCheektowaga$430K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.